Ventricular Tachycardia (VT)
21
5
7
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 21 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (21)
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia Substrate
Cardiac RadiothErapy for VEntricular Tachycardia II
Metabolomic Profiling in Ischemic and Non-Ischemic Cardiomyopathy Patients With Ventricular Arrhythmias
Sympathetic Ablation for Ventricular Arrhythmias
Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Predicting Severe Cardiac Arrhythmias in the Perioperative Period Using AI-ECG
Electrophysiological Registry Duesseldorf
Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry
Ventricular Tachycardia Cohort
Clinical Study on the Efficiency of Rapid Arrhythmia Mapping Using EasyStars™ High Density Mapping Catheter Applications
Transcutaneous Vagus Nerve Stimulation for Ventricular Arrhythmias
Complex Arrhythmia Registry
Stereotactic Radiosurgery as Second-line Therapy for Ventricular Tachycardia
Ventricular Tachycardia Ablation Through Radiation Therapy Consortium: Concept Description of an Observational Retrospective Multicentric Trial
VT ART Consortium: Radioablation for Ventricular Tachycardia
Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)
Evolution of Intracardiac Electrograms Recorded by Left Bundle Branch Pacing Lead in Patients With ICD or CRT-D
Antiarrhythmics or Ablation for Ventricular Tachycardia 2
A Study to Evaluate the Effect of Vagus Nerve Stimulation in Patients Undergoing VT Ablation